VOR - Vor Biopharma - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

VOR is currently covered by 8 analysts with an average price target of $10.87. This is a potential upside of $10.7 (6294.12%) from yesterday's end of day stock price of $0.17.

Vor Biopharma's activity chart (see below) currently has 15 price targets and 40 ratings on display. The stock rating distribution of VOR is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for VOR is $3, Lowest price target is $3, average price target is $10.67.

Most recent stock forecast was given by SILVAN TUERKCAN from JMP on 30-Dec-2024. First documented stock forecast 02-Mar-2021.

Currently out of the existing stock ratings of VOR, 25 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

4 months 12 days ago
(30-Dec-2024)

0/6 (0%)

$9.12 (316.67%)

Buy

5 months 2 days ago
(10-Dec-2024)

0/5 (0%)

$12.58 (255.69%)

Buy

$22

6 months 4 days ago
(08-Nov-2024)

0/2 (0%)

$16.12 (274.15%)

Buy

$3

$2 (200.00%)

$10

8 months 28 days ago
(14-Aug-2024)

0/4 (0%)

$2.17 (261.45%)

Buy

11 months 29 days ago
(13-May-2024)

0/4 (0%)

$13.58 (307.24%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is VOR (Vor Biopharma) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on VOR (Vor Biopharma) with a proven track record?

SWAYAMPAKULA RAMAKANTH

Which analyst has the current lower performing score on VOR (Vor Biopharma) with a proven track record?

DAVID NIERENGARTEN

Which analyst has the most public recommendations on VOR (Vor Biopharma)?

Swayampakula Ramakanth has 13 price targets and 11 ratings on VOR

Which analyst is the currently most bullish on VOR (Vor Biopharma)?

John Walsh with highest potential upside - $15.79

Which analyst is the currently most reserved on VOR (Vor Biopharma)?

Swayampakula Ramakanth with lowest potential downside - -$0

Vor Biopharma in the News

Vor Bio Announces Exploration of Strategic Alternatives to Maximize Shareholder Value

CAMBRIDGE, Mass., May 08, 2025 (GLOBE NEWSWIRE) — Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that, based on currently available clinical data from its key clinical programs and a challenging fundraising environment, the Board of Directors has approved the initiation of a process to explore a range of strategic...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?